Literature DB >> 25518811

Risk factors for colorectal neoplasms based on colonoscopy and pathological diagnoses of Chinese citizens: a multicenter, case-control study.

Miao Qin1, Lan-Qing Ma, Juan Tan, Ya-Rong Chen, Liang-Ru Zhu, Rong Lin, Wei-Ling Hu, Jing-Nan Li, Kun-He Zhang, Yan Wang, Jian-Sheng Li, Bing Xiao, Hao-Yan Chen, Ying-Xuan Chen, Jing-Yuan Fang.   

Abstract

PURPOSE: Since observational data in the urban residents are required to better assess the risk factors of colorectal neoplasm occurrence and the effectiveness of colonoscopy screening and surveillance, we conducted a case-control study at multicenters in China to identify patient characteristics and neoplasm features of colorectal adenoma (CRA) and colorectal carcinoma (CRC).
METHODS: A total of 4089 patients who had undergone a colonoscopy from 19 hospitals were enrolled, of which 1106 had CRA and 466 had CRC. They were compared with controls. The analysis provides features and risk factors of colorectal neoplasm using multivariate logistic regression.
RESULTS: Increasing age, a family history of colorectal cancer or previous cases of colorectal adenoma or hypertension disease, gastrointestinal surgery, regular intake of pickled food (adjusted odds ratio [aOR] 1.42, 95 % confidence interval [CI], 1.048-1.924), consumption of alcohol, and a positive result of fecal occult blood testing (FOBT; aOR 2.509, 95 % CI 1.485-4.237) were associated with an increased risk of CRA. In the CRC group, increasing age, regular intake of pickled foods, and a positive FOBT result were risk factors. In addition, a positive abdominal computed tomography (CT) before a colonoscopy and physical signs of emaciation were also significantly associated with an increasing risk of colorectal carcinoma. Regular intake of vegetables decreased the risk of both CRA and CRC.
CONCLUSIONS: Age, pickled foods, and a positive FOBT are risk factors for colorectal neoplasm. Vegetable intake was associated with a decreased risk of CRA and CRC.

Entities:  

Mesh:

Year:  2014        PMID: 25518811     DOI: 10.1007/s00384-014-2090-9

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  41 in total

1.  Daily aspirin reduces colorectal cancer incidence in patients with Lynch syndrome.

Authors:  Mary Kay Barton
Journal:  CA Cancer J Clin       Date:  2012-03-12       Impact factor: 508.702

2.  Associations between lifestyles and neutrophil-lymphocyte and platelet-lymphocyte ratios in colorectal cancer.

Authors:  Chuyuan Hong; Yisheng Wei; Jianxin Jiang; Chuxiong Zhao; Guojian Liang; Guoqiang Wang; Hui Yang
Journal:  Asia Pac J Clin Oncol       Date:  2013-05-29       Impact factor: 2.601

3.  Meat consumption and risk of colorectal cancer: a meta-analysis of prospective studies.

Authors:  Susanna C Larsson; Alicja Wolk
Journal:  Int J Cancer       Date:  2006-12-01       Impact factor: 7.396

4.  Risk factors for gastric cancer in South India.

Authors:  B Sumathi; S Ramalingam; U Navaneethan; V Jayanthi
Journal:  Singapore Med J       Date:  2009-02       Impact factor: 1.858

5.  Metabolic syndrome components and colorectal adenoma in the CLUE II cohort.

Authors:  Konstantinos K Tsilidis; Frederick L Brancati; Michael N Pollak; Nader Rifai; Sandra L Clipp; Judith Hoffman-Bolton; Kathy J Helzlsouer; Elizabeth A Platz
Journal:  Cancer Causes Control       Date:  2009-09-23       Impact factor: 2.506

Review 6.  Nutrition and colorectal cancer.

Authors:  J D Potter
Journal:  Cancer Causes Control       Date:  1996-01       Impact factor: 2.506

7.  Report of incidence and mortality in China cancer registries, 2009.

Authors:  Wanqing Chen; Rongshou Zheng; Siwei Zhang; Ping Zhao; Guanglin Li; Lingyou Wu; Jie He
Journal:  Chin J Cancer Res       Date:  2013-02       Impact factor: 5.087

8.  Report of incidence and mortality in china cancer registries, 2008.

Authors:  Wan-Qing Chen; Rong-Shou Zheng; Si-Wei Zhang; Ni Li; Ping Zhao; Guang-Lin Li; Liang-You Wu; Jie He
Journal:  Chin J Cancer Res       Date:  2012-09       Impact factor: 5.087

9.  Cumulative risk of colon cancer up to age 70 years by risk factor status using data from the Nurses' Health Study.

Authors:  Esther K Wei; Graham A Colditz; Edward L Giovannucci; Charles S Fuchs; Bernard A Rosner
Journal:  Am J Epidemiol       Date:  2009-09-01       Impact factor: 4.897

10.  Development of a risk score for colorectal cancer in men.

Authors:  Jane A Driver; J Michael Gaziano; Rebecca P Gelber; I-Min Lee; Julie E Buring; Tobias Kurth
Journal:  Am J Med       Date:  2007-03       Impact factor: 4.965

View more
  5 in total

1.  The First Screening Program for Colorectal Cancer in the North of Iran.

Authors:  Hossein-Ali Nikbakht; Javad Shokri-Shirvani; Hassan Ashrafian-Amiri; Haleh Ghaem; Ali Jafarnia; Sedigheh Alijanpour; Seyed-Mostaffa Mirzad; Soheil Hassanipour
Journal:  J Gastrointest Cancer       Date:  2020-03

2.  The extracellular matrix protein mindin attenuates colon cancer progression by blocking angiogenesis via Egr-1-mediated regulation.

Authors:  L-F Wang; Y-S Liu; B Yang; P Li; X-S Cheng; C-X Xiao; J-J Liu; S Li; J-L Ren; B Guleng
Journal:  Oncogene       Date:  2017-10-09       Impact factor: 9.867

3.  Mindin serves as a tumour suppressor gene during colon cancer progression through MAPK/ERK signalling pathway in mice.

Authors:  Xiao-Shen Cheng; Ya-Ni Huo; Yan-Yun Fan; Chuan-Xing Xiao; Xiao-Mei Ouyang; Lai-Ying Liang; Ying Lin; Jian-Feng Wu; Jian-Lin Ren; Bayasi Guleng
Journal:  J Cell Mol Med       Date:  2020-07-02       Impact factor: 5.310

4.  Effect of Ulcerative Colitis on Incidence of Colorectal Cancer: Results from the Nationwide Population-Based Cohort Study (2003-2013).

Authors:  Jung-Kyu Choi; Dong-Wook Kim; Sang-Yun Shin; Eun-Cheol Park; Jung-Gu Kang
Journal:  J Cancer       Date:  2016-03-21       Impact factor: 4.207

5.  Prostate cancer patients may have an increased risk of coexisting advanced colorectal neoplasms.

Authors:  Sun-Hye Ko; Myong Ki Baeg; Woong Jin Bae; Pumsoo Kim; Myung-Gyu Choi
Journal:  Onco Targets Ther       Date:  2016-09-09       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.